The Australian Government is providing $31.5 million for COVID-19 research to support medical researchers to drive, and contribute to, global efforts to understand and treat
Novavax COVID-19 vaccine (Nuvaxovid) has been provisionally approved by the Australian Therapeutic Goods Agency (TGA) for use in adolescents aged 12 to 17 years. The
The Department of Health and Aged Care is extending its Expression of Interest (EOI) process for COVID-19 in-reach vaccination clinics until 31 December 2022, allowing
NSW Health has revised the COVID-19 reinfection period from 12 weeks down to four weeks effective from today. People who have previously had COVID-19 should
The country’s largest union, the Australian Nursing and Midwifery Federation (ANMF), is calling on the new Albanese Government to reverse a decision to scrap COVID
From 1st July 2022, Australians experiencing mental ill-health will no longer have access to some aspects of telehealth after the federal government failed to extend the
According to a new study led by Monash University, of those admitted to the ICU with COVID-19, after accounting for age and how sick patients
The Australian Government will contribute funding towards a new Financial Intermediary Fund (FIF) for pandemics which will be established at the World Bank, as part
Australian COVID-19 cases after the peak of the Omicron wave were at least twice as high as reported to authorities, a blood antibody study shows.
On 25 March 2022, ATAGI recommended an additional winter booster dose (4th dose for most people) for the highest risk groups: the elderly, residents of